XML 30 R5.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Net income $ 11,964 $ 14,303
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 13,355 13,100
Provision for losses on accounts receivable 1,188 1,511
Stock-based compensation expense 1,616 2,924
Deferred income tax (benefit) expense 1,270 3,547
Amortization of deferred financing costs 289 420
Amortization of capitalized commissions on preneed contracts 417 449
Accretion of discount on convertible subordinated notes 178 1,961
Accretion of debt discount on senior notes 366 154
Net loss on early extinguishment of debt 0 936
Net loss on sale of business and other assets 4,067 408
Gain on insurance reimbursements (638) 0
Goodwill and other impairments 730 0
Other 121 0
Changes in operating assets and liabilities that provided (used) cash:    
Accounts and preneed receivables (2,495) (3,010)
Inventories, prepaid and other current assets 1,138 (1,911)
Intangible and other non-current assets (241) (345)
Preneed funeral and cemetery trust investments (4,376) (6,104)
Accounts payable (3,852) (735)
Accrued and other liabilities 6,749 3,761
Deferred preneed funeral and cemetery revenue 804 6,292
Deferred preneed funeral and cemetery receipts held in trust 3,411 1,056
Net cash provided by operating activities 36,061 38,717
Cash flows from investing activities:    
Acquisitions and land for new construction 0 (37,970)
Proceeds from insurance reimbursements 1,247 0
Proceeds from the sale of business and other assets 967 0
Capital expenditures (11,479) (9,037)
Net cash used in investing activities (9,265) (47,007)
Cash flows from financing activities:    
Payments against the term loan 0 (127,500)
Borrowings from the credit facility 28,200 96,000
Payments against the credit facility (37,300) (188,000)
Payments of Debt Issuance Costs (113) (1,551)
Redemption of the 2.75% convertible subordinated notes (27) (75,229)
Payment of transaction costs related to the redemption of the 2.75% convertible subordinated notes 0 (845)
Proceeds from the issuance of the 6.625% senior notes 0 320,125
Payments on other long-term debt and obligations under finance leases (1,370) (1,031)
Payments on contingent consideration recorded at acquisition date (162) (138)
Proceeds from the exercise of stock options and employee stock purchase plan contributions 1,155 1,075
Taxes paid on restricted stock vestings and exercise of non-qualified options (194) (651)
Dividends paid on common stock (4,061) (4,076)
Purchase of treasury stock (7,756) 0
Net cash provided by (used in) financing activities (21,628) 16,812
Net increase in cash and cash equivalents 5,168 8,522
Cash and cash equivalents at beginning of period 644 952
Cash and cash equivalents at end of period 5,812 9,474
Senior Notes [Member]    
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization of deferred financing costs 103 44
Accretion of debt discount on senior notes 366 154
Cash flows from financing activities:    
Payments of Debt Issuance Costs $ 0 $ (1,367)